These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9651600)

  • 61. Improved Doppler signal intensity in coronary arteries after intravenous peripheral injection of a lung-crossing contrast agent (SHU 508A).
    Iliceto S; Caiati C; Aragona P; Verde R; Schlief R; Rizzon P
    J Am Coll Cardiol; 1994 Jan; 23(1):184-90. PubMed ID: 8277078
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Retrograde-delivered cardioplegia is not distributed equally to the right ventricular free wall and septum.
    Winkelmann J; Aronson S; Young CJ; Fernandez A; Lee BK
    J Cardiothorac Vasc Anesth; 1995 Apr; 9(2):135-9. PubMed ID: 7780068
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations.
    Lindner JR; Villanueva FS; Dent JM; Wei K; Sklenar J; Kaul S
    Am Heart J; 2000 Feb; 139(2 Pt 1):231-40. PubMed ID: 10650295
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Second harmonic imaging of an intravenously administered echocardiographic contrast agent: Visualization of coronary arteries and measurement of coronary blood flow.
    Mulvagh SL; Foley DA; Aeschbacher BC; Klarich KK; Seward JB
    J Am Coll Cardiol; 1996 May; 27(6):1519-25. PubMed ID: 8626968
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ultrasound scattering properties of Albunex microspheres.
    de Jong N; Hoff L
    Ultrasonics; 1993; 31(3):175-81. PubMed ID: 8484195
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical utility of the transpulmonary echo enhancing agent Levovist to improve diagnostic confidence in echocardiography.
    Nanda NC
    J Clin Ultrasound; 1997 Oct; 25(8):411-9. PubMed ID: 9321712
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Myocardial contrast agents: recent advances and future directions.
    Mayer S; Grayburn PA
    Prog Cardiovasc Dis; 2001; 44(1):33-44. PubMed ID: 11533925
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The mechanism and clinical implication of improved left ventricular videointensity following intravenous injection of multi-fold dilutions of albumin with dextrose.
    Porter TR; Xie F; Kricsfeld A
    Int J Card Imaging; 1995 Jun; 11(2):117-25. PubMed ID: 7673759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of contrast agents for delineation of vessel wall boundary by intracoronary ultrasound after coronary angioplasty in human.
    Nishino M; Tanouchi J; Kawabata M; Tanaka K; Ito T; Kato J; Yamada Y; Kamada T
    Catheter Cardiovasc Interv; 1999 May; 47(1):6-13. PubMed ID: 10385151
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improved echocardiographic delineation of left ventricular thrombus with the use of intravenous second-generation contrast image enhancement.
    Thanigaraj S; Schechtman KB; Pérez JE
    J Am Soc Echocardiogr; 1999 Dec; 12(12):1022-6. PubMed ID: 10588776
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Myocardial contrast echocardiography demonstrates myocardial hypoperfusion in the LAD territory in patients with acute chest pain at rest--a prospective study using power Doppler harmonic imaging with intravenous bolus application.
    Hagendorff A; Goeckritz A; Pfeiffer D; Becher H
    Eur J Echocardiogr; 2004 Mar; 5(2):132-41. PubMed ID: 15036025
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Feasibility of right ventricular myocardial opacification by contrast echocardiography and comparison with left ventricular intensity.
    Masugata H; Cotter B; Ohmori K; Kwan OL; Mizushige K; DeMaria AN
    Am J Cardiol; 1999 Nov; 84(9):1137-40, A11. PubMed ID: 10569688
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Some considerations on the measurements of mean frequency shift and integrated backscatter following administration of Albunex.
    Wang SH; Chang PH; Shung KK; Levene HB
    Ultrasound Med Biol; 1996; 22(4):441-51. PubMed ID: 8795171
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Myocardial contrast echocardiography in humans. II. Assessment of coronary blood flow reserve.
    Keller MW; Glasheen W; Smucker ML; Burwell LR; Watson DD; Kaul S
    J Am Coll Cardiol; 1988 Oct; 12(4):925-34. PubMed ID: 3417990
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Optimal setting of focus points for myocardial contrast echocardiography with intravenous Optison (FS-69): an experimental study].
    Daimon M; Beppu S; Ishikura F; Ueda H; Kobayashi H; Kashiwagi Y; Yagura S; Yoshikawa J
    J Cardiol; 2001 Apr; 37(4):201-7. PubMed ID: 11337929
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intravenous injection of Albunex microspheres causes thromboxane mediated pulmonary hypertension in pigs, but not in monkeys or rabbits.
    Ostensen J; Hede R; Myreng Y; Ege T; Holtz E
    Acta Physiol Scand; 1992 Mar; 144(3):307-15. PubMed ID: 1533987
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical usefulness of contrast-enhanced intracoronary ultrasound (ICUS) and evaluation of suitable contrast agents for ICUS].
    Tanaka K; Nishino M; Tanouchi J
    Nihon Rinsho; 1998 Apr; 56(4):942-6. PubMed ID: 9577613
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of inhaled gases on the ultrasound contrast produced by microspheres containing air or perfluoropropane in anesthetized dogs.
    Wible J; Wojdyla J; Bugaj J; Brandenburger G
    Invest Radiol; 1998 Dec; 33(12):871-9. PubMed ID: 9851821
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Optimization of the size distribution and myocardial contrast effect of perfluorocarbon-filled albumin microbubbles by lyophilization under continuous negative pressure.
    Chen S; Wang Z; Zhou YT; Grayburn PA
    J Am Soc Echocardiogr; 2000 Aug; 13(8):748-53. PubMed ID: 10936818
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Visualization of coronary arteries using intravenous contrast agent and real-time 3-dimensional echocardiography in a patient with hypertrophic cardiomyopathy.
    Tsutsui JM; Arteaga E; Brie JA; Mady C; Andrade JL; Ramires JF; Mathias W
    J Am Soc Echocardiogr; 2005 Feb; 18(2):188-91. PubMed ID: 15682059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.